Are Options Traders Bullish on AERI?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

About AERI

Aerie is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie recently reported the successful results of its second Phase 3 registration trial in the United States named Rocket 2, where the primary efficacy endpoint was to demonstrate non-inferiority of IOP lowering for Rhopressa compared to timolol. Rocket 3, a 12-month safety-only study, is currently in progress, and Aerie has recently commenced a fourth Phase 3 trial for Rhopressa, named Rocket 4. Aerie also completed in 2014 a Phase 2b clinical trial in which Roclatan met the primary efficacy endpoint, demonstrating the statistical superiority of Roclatan to each of its components, and recently commenced the first Phase 3 registration trial for Roclatan, named Mercury 1. Aerie also recently announced research collaborations with GrayBug, Inc. and Ramot at Tel Aviv University as it further builds its pipeline for future growth.
Primary Exchange: NASDAQ
SIC Biological Products, (No Diagnostic Substances)
NAICS Pharmaceutical Preparation Manufacturing

AERI is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 274.1 M 2.74063E+08 235 235 0.1% 0.000957548 574 K 574436
EQWS Invesco Russell 2000 Equal Weight ETF 20.0 M 2E+07 1,952 1952 0.03% 0.0003 6 K 5985
FHLC Fidelity MSCI Health Care Index ETF 1.5 B 1.5E+09 357 357 0.04% 0.00043992 661 K 660575
FTLS First Trust Long/Short Equity 200.7 M 2.00668E+08 245 245 -0.13% -0.0013 -242 K -241646
IBB iShares Nasdaq Biotechnology Index Fund 8.2 B 8.22605E+09 224 224 0.26% 0.0026 21.1 M 2.11286E+07
IHE iShares U.S. Pharmaceutical ETF 389.5 M 3.89459E+08 47 47 1.3% 0.013 5.0 M 5003670
ITOT iShares Core S&P Total U.S. Stock Market ETF 16.5 B 1.65381E+10 3,387 3387 0.01% 0.0001 1.1 M 1071070
IWM iShares Russell 2000 ETF 41.5 B 4.15155E+10 2,023 2023 0.08% 0.0008 32.2 M 3.22476E+07
IWO iShares Russell 2000 Growth ETF 8.9 B 8.86114E+09 1,249 1249 0.15% 0.0015 13.3 M 1.33293E+07
IWV iShares Russell 3000 ETF 9.5 B 9.52999E+09 2,990 2990 0.01% 0.0001 526 K 526327
JKK iShares Morningstar Small-Cap Growth ETF 164.1 M 1.64111E+08 252 252 0.29% 0.0029 475 K 475368
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.7 B 1.7E+09 1,015 1015 0.02% 0.000232301 404 K 404261
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.3 B 1.34684E+09 2,017 2017 0.01% 0.000137 183 K 183484
UBIO Proshares UltraPro Nasdaq Biotechnology 34.6 M 3.45696E+07 229 229 0.06% 0.000578217 65 K 65444
URTY ProShares UltraPro Russell2000 114.2 M 1.14192E+08 2,034 2034 0.01% 0.000139525 54 K 54094
UWM ProShares Ultra Russell2000 163.2 M 1.6324E+08 2,034 2034 0.03% 0.00029193 104 K 104163
XPH SPDR S&P Pharmaceuticals ETF 249.5 M 2.4951E+08 47 47 2.91% 0.0290863 7.3 M 7255111

Wait, Before You Leave...